Literature DB >> 32827212

Organized immune cell interactions within tumors sustain a productive T-cell response.

Maria A Cardenas1, Nataliya Prokhnevska1, Haydn T Kissick1,2,3.   

Abstract

Tumor-infiltrating CD8 T cells are associated with improved patient survival and response to immunotherapy in various cancers. Persistent antigen leads to CD8 T-cell exhaustion, where proliferation/self-renewal and killing are divided within distinct subsets of CD8 T cells in the tumor. CD8 T-cell responses in chronic antigen settings must be maintained for long periods of time, suggesting that mechanisms that regulate chronic CD8 T-cell responses may differ from those in acute settings. Currently, factors that regulate the maintenance of stem-like CD8 T cells in the tumor or their differentiation into terminally differentiated cells are unknown. In this review, we discuss the role of dendritic cells in the activation and differentiation of CD8 T-cell subsets within secondary lymphoid tissue and tumors. In addition, we examine changes in CD4 T-cell differentiation in response to chronic antigens and consider how subset-specific mechanisms could assist the stem-like and terminally differentiated CD8 T-cell subsets. Finally, we highlight how tumor-infiltrating CD4 T cells and dendritic cells interact with CD8 T cells within organized lymphoid-like areas in the tumor and propose a CD8 T-cell differentiation model that requires the collaboration of CD4 T cells and dendritic cells. These organized interactions coordinate the anti-tumor response and control disease progression by mechanisms that regulate CD8 T-cell differentiation, which permit the maintenance of an effective balance of stem-like and terminally differentiated CD8 T cells. © The Japanese Society for Immunology. 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD4 T cells; CD8 T-cell differentiation; T-cell exhaustion; dendritic cells; lymphoid-like niches

Mesh:

Substances:

Year:  2021        PMID: 32827212      PMCID: PMC7771196          DOI: 10.1093/intimm/dxaa057

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  115 in total

Review 1.  T cell dynamics in HIV-1 infection.

Authors:  Daniel C Douek; Louis J Picker; Richard A Koup
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  CD8+ T Cells Orchestrate pDC-XCR1+ Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming.

Authors:  Anna Brewitz; Sarah Eickhoff; Sabrina Dähling; Thomas Quast; Sammy Bedoui; Richard A Kroczek; Christian Kurts; Natalio Garbi; Winfried Barchet; Matteo Iannacone; Frederick Klauschen; Waldemar Kolanus; Tsuneyasu Kaisho; Marco Colonna; Ronald N Germain; Wolfgang Kastenmüller
Journal:  Immunity       Date:  2017-02-09       Impact factor: 31.745

Review 3.  Dendritic cells in cancer immunology and immunotherapy.

Authors:  Stefanie K Wculek; Francisco J Cueto; Adriana M Mujal; Ignacio Melero; Matthew F Krummel; David Sancho
Journal:  Nat Rev Immunol       Date:  2019-08-29       Impact factor: 53.106

4.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

5.  CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity.

Authors:  Laura M Snell; Bethany L MacLeod; Jaclyn C Law; Ivan Osokine; Heidi J Elsaesser; Kebria Hezaveh; Russell J Dickson; Marc A Gavin; Cynthia J Guidos; Tracy L McGaha; David G Brooks
Journal:  Immunity       Date:  2018-10-09       Impact factor: 31.745

6.  Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.

Authors:  Roy S Herbst; Jean-Charles Soria; Marcin Kowanetz; Gregg D Fine; Omid Hamid; Michael S Gordon; Jeffery A Sosman; David F McDermott; John D Powderly; Scott N Gettinger; Holbrook E K Kohrt; Leora Horn; Donald P Lawrence; Sandra Rost; Maya Leabman; Yuanyuan Xiao; Ahmad Mokatrin; Hartmut Koeppen; Priti S Hegde; Ira Mellman; Daniel S Chen; F Stephen Hodi
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

7.  Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.

Authors:  Yannick Simoni; Etienne Becht; Michael Fehlings; Chiew Yee Loh; Si-Lin Koo; Karen Wei Weng Teng; Joe Poh Sheng Yeong; Rahul Nahar; Tong Zhang; Hassen Kared; Kaibo Duan; Nicholas Ang; Michael Poidinger; Yin Yeng Lee; Anis Larbi; Alexis J Khng; Emile Tan; Cherylin Fu; Ronnie Mathew; Melissa Teo; Wan Teck Lim; Chee Keong Toh; Boon-Hean Ong; Tina Koh; Axel M Hillmer; Angela Takano; Tony Kiat Hon Lim; Eng Huat Tan; Weiwei Zhai; Daniel S W Tan; Iain Beehuat Tan; Evan W Newell
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

8.  Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription.

Authors:  Hiroyoshi Taniguchi; Naoya Kato; Motoyuki Otsuka; Tadashi Goto; Hideo Yoshida; Yasushi Shiratori; Masao Omata
Journal:  J Med Virol       Date:  2004-01       Impact factor: 2.327

9.  Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Authors:  Hanjie Li; Anne M van der Leun; Ido Yofe; Yaniv Lubling; Dikla Gelbard-Solodkin; Alexander C J van Akkooi; Marlous van den Braber; Elisa A Rozeman; John B A G Haanen; Christian U Blank; Hugo M Horlings; Eyal David; Yael Baran; Akhiad Bercovich; Aviezer Lifshitz; Ton N Schumacher; Amos Tanay; Ido Amit
Journal:  Cell       Date:  2018-12-27       Impact factor: 41.582

10.  The evolutionary history of 2,658 cancers.

Authors:  Moritz Gerstung; Clemency Jolly; Ignaty Leshchiner; Stefan C Dentro; Santiago Gonzalez; Daniel Rosebrock; Thomas J Mitchell; Yulia Rubanova; Pavana Anur; Kaixian Yu; Maxime Tarabichi; Amit Deshwar; Jeff Wintersinger; Kortine Kleinheinz; Ignacio Vázquez-García; Kerstin Haase; Lara Jerman; Subhajit Sengupta; Geoff Macintyre; Salem Malikic; Nilgun Donmez; Dimitri G Livitz; Marek Cmero; Jonas Demeulemeester; Steven Schumacher; Yu Fan; Xiaotong Yao; Juhee Lee; Matthias Schlesner; Paul C Boutros; David D Bowtell; Hongtu Zhu; Gad Getz; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Florian Markowetz; Ville Mustonen; Ke Yuan; Wenyi Wang; Quaid D Morris; Paul T Spellman; David C Wedge; Peter Van Loo
Journal:  Nature       Date:  2020-02-06       Impact factor: 49.962

View more
  3 in total

1.  Spatially organized multicellular immune hubs in human colorectal cancer.

Authors:  Karin Pelka; Matan Hofree; Jonathan H Chen; Siranush Sarkizova; Joshua D Pirl; Vjola Jorgji; Alborz Bejnood; Danielle Dionne; William H Ge; Katherine H Xu; Sherry X Chao; Daniel R Zollinger; David J Lieb; Jason W Reeves; Christopher A Fuhrman; Margaret L Hoang; Toni Delorey; Lan T Nguyen; Julia Waldman; Max Klapholz; Isaac Wakiro; Ofir Cohen; Julian Albers; Christopher S Smillie; Michael S Cuoco; Jingyi Wu; Mei-Ju Su; Jason Yeung; Brinda Vijaykumar; Angela M Magnuson; Natasha Asinovski; Tabea Moll; Max N Goder-Reiser; Anise S Applebaum; Lauren K Brais; Laura K DelloStritto; Sarah L Denning; Susannah T Phillips; Emma K Hill; Julia K Meehan; Dennie T Frederick; Tatyana Sharova; Abhay Kanodia; Ellen Z Todres; Judit Jané-Valbuena; Moshe Biton; Benjamin Izar; Conner D Lambden; Thomas E Clancy; Ronald Bleday; Nelya Melnitchouk; Jennifer Irani; Hiroko Kunitake; David L Berger; Amitabh Srivastava; Jason L Hornick; Shuji Ogino; Asaf Rotem; Sébastien Vigneau; Bruce E Johnson; Ryan B Corcoran; Arlene H Sharpe; Vijay K Kuchroo; Kimmie Ng; Marios Giannakis; Linda T Nieman; Genevieve M Boland; Andrew J Aguirre; Ana C Anderson; Orit Rozenblatt-Rosen; Aviv Regev; Nir Hacohen
Journal:  Cell       Date:  2021-08-26       Impact factor: 66.850

2.  Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.

Authors:  Simon Wabitsch; Justin D McCallen; Olena Kamenyeva; Benjamin Ruf; John C McVey; Juraj Kabat; Juliane S Walz; Yaron Rotman; Kylynda C Bauer; Amanda J Craig; Marie Pouzolles; Ira Phadke; Vanessa Catania; Benjamin L Green; Claude Fu; Laurence P Diggs; Bernd Heinrich; Xin Wei Wang; Chi Ma; Tim F Greten
Journal:  J Hepatol       Date:  2022-04-01       Impact factor: 30.083

3.  cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.

Authors:  Sanjay Mishra; Manish Charan; Rajni Kant Shukla; Pranay Agarwal; Swati Misri; Ajeet K Verma; Dinesh K Ahirwar; Jalal Siddiqui; Kirti Kaul; Neety Sahu; Kunj Vyas; Ayush Arpit Garg; Anum Khan; Wayne O Miles; Jonathan W Song; Nidhi Bhutani; Ramesh K Ganju
Journal:  J Exp Clin Cancer Res       Date:  2022-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.